Written by the Nuvirox Research Team
Key points
- Most of your NAD+ is not synthesised from scratch. It is recycled from nicotinamide, the fragment left behind every time an enzyme consumes NAD+ — this is the salvage pathway, and it dominates in most tissues.
- One enzyme, NAMPT, is rate-limiting for the whole loop. In human muscle biopsies its abundance falls with age, and both aerobic and resistance training raise it back.
- The salvage pathway is also on a clock. NAMPT expression is directly controlled by the core circadian machinery, so NAD+ availability oscillates across the day.
Short answer: your body makes only a small fraction of its NAD+ from scratch; the overwhelming majority is salvaged — rebuilt from the nicotinamide left over when NAD+ is consumed. That single fact explains why NAD+ levels can fall without any change in diet, why one enzyme gets so much attention, and why supplemental precursors work the way they do. It also explains their limits.
What is the salvage pathway, in plain terms?
NAD+ has two jobs, and one of them destroys it. As an electron carrier in metabolism, it is used and regenerated endlessly without net loss. But as a substrate for signalling enzymes — sirtuins, PARPs, CD38 — the molecule is cleaved apart. Each of those reactions leaves nicotinamide behind.
The salvage pathway is the recovery operation. Nicotinamide is captured by the enzyme NAMPT and converted to nicotinamide mononucleotide (NMN). NMNAT enzymes then cap NMN with an adenylyl group and it is NAD+ again. Two steps, and the molecule is back in service. Reviews of NAD+ biosynthesis consistently identify this route as the dominant one for intracellular NAD+ in most tissues.
Why does one enzyme matter so much?
Because NAMPT is the narrow point. Everything upstream of it can be plentiful and the loop still runs at whatever speed NAMPT allows. That makes NAMPT abundance a reasonable proxy for salvage capacity, and it is measurable in human tissue.
Study snapshot
| Design | Cross-sectional biopsy analysis plus 12-week exercise intervention |
| Tissue | Human vastus lateralis skeletal muscle; separate adipose cohort |
| n | 57 for the age correlation; younger (≤35) and older (≥55) groups trained |
| Finding | NAMPT correlated negatively with age (r² = 0.297, P < 0.001). Aerobic training raised NAMPT 12% (young) and 28% (older); resistance training 25% and 30%. VO2peak was the best single predictor of NAMPT. |
| Caveat | Adipose tissue NAMPT was unaffected by age or by six weeks of interval training — the effect is tissue-specific, not systemic. |
What human studies actually show
Salvage capacity declines with age in muscle, and training reverses it. The biopsy work above is the clearest human demonstration that this is not merely a mouse phenomenon. Both training modes worked, and the older group responded at least as well as the younger one.
The pathway is under circadian control. A landmark 2009 study showed that the CLOCK:BMAL1 complex binds the NAMPT promoter and drives its transcription, while SIRT1 — itself NAD+-dependent — feeds back onto the same promoter. NAD+ availability therefore oscillates with the day, and the clock and the metabolite regulate each other. A 2023 PNAS study extended this, showing NAMPT-dependent NAD+ biosynthesis shapes circadian metabolism differently in different tissues.
The honest counterweight: most of the mechanistic detail is not from humans. The circadian findings come from mouse liver, mouse embryonic fibroblasts and targeted genetic knockouts — tools you cannot deploy in people. The human data is largely correlational or limited to biomarker responses. Nobody has shown that manipulating human NAMPT rhythm changes how anyone feels. Anyone presenting the circadian NAD+ story as settled clinical fact is overreaching.
How do supplements interact with this loop?
Precursors do not bypass the salvage pathway; they enter it. Nicotinamide riboside is phosphorylated by NRK enzymes straight to NMN, stepping past the NAMPT bottleneck. NMN itself needs only the NMNAT step. Plain nicotinamide re-enters at the top and is therefore still subject to the NAMPT rate limit.
That is the actual mechanistic argument for NR and NMN over plain nicotinamide, and it is a reasonable one. We compare the three routes in detail in NR vs. NMN vs. NAD+.
| Entry point | Enzyme needed | Bypasses NAMPT? |
|---|---|---|
| Nicotinamide (NAM) | NAMPT, then NMNAT | No |
| Nicotinamide riboside (NR) | NRK1/2, then NMNAT | Yes |
| NMN | NMNAT only | Yes |
| Tryptophan (de novo) | Multi-step kynurenine route | Separate pathway |
Why does NAD+ fall with age if it is recycled?
Two reasons, and they pull in the same direction. Salvage capacity drops — less NAMPT, as the biopsy data shows. And consumption rises: the NAD+-consuming enzyme CD38 becomes markedly more abundant in ageing tissue, degrading both NAD+ and its precursor NMN. We cover that side in CD38, the enzyme that eats your NAD+ as you age, and the broader question in does NAD+ actually decline with age.
What the salvage pathway won’t do
It will not explain fatigue on its own. Salvage capacity in muscle correlates with training status more strongly than with anything you can buy, and the strongest single predictor in that dataset was aerobic fitness. If NAMPT is the target, exercise has better human evidence for hitting it than any supplement does.
It also will not rescue a genuine dietary shortfall of the vitamin itself. Salvage recycles what is already in the system; it does not create niacin equivalents from nothing. When intake is truly inadequate the picture is clinical — see what niacin deficiency actually looks like.
Frequently asked questions
Is the salvage pathway the same in every tissue?
No, and that matters. The salvage route dominates in most tissues, but liver retains meaningful capacity to build NAD+ from tryptophan, and the exercise data showed NAMPT rising in skeletal muscle while adipose tissue was unaffected. Systemic claims from single-tissue data should be treated cautiously.
Does fasting or exercise raise NAD+ through this pathway?
Exercise has the clearest human evidence: twelve weeks of aerobic or resistance training raised skeletal muscle NAMPT abundance in both younger and older adults. Fasting effects on human NAD+ are far less well characterised.
If NAD+ is recycled, why would anyone need a supplement?
Because recycling is not lossless and capacity is not fixed. Some nicotinamide is methylated and excreted rather than recaptured, consumption rises with age and DNA damage, and NAMPT abundance falls. A precursor addresses the input side of that balance, not the consumption side.
Does the time of day I take a precursor matter?
Mechanistically it is a fair question, given that NAMPT expression is clock-controlled. Practically, no human trial has compared morning versus evening dosing on any outcome that matters. Consistency is worth more than timing here.
From Nuvirox
Why we formulated NAD+ Restore.
NAD+ Restore is built around nicotinamide riboside specifically because it enters the salvage loop below the NAMPT bottleneck — the step that human biopsy data shows declines with age.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
- 150 mg trans-resveratrol (Japanese Knotweed) + 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support.
- 10 mg galactomannans from fenugreek — to support absorption.
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
The bottom line
The salvage pathway is the reason NAD+ biology behaves the way it does. Your body recycles nicotinamide back into NAD+ continuously, one enzyme sets the pace, that enzyme becomes less abundant with age in human muscle, and training raises it again. Supplemental precursors are a legitimate way to feed the loop from a point below its bottleneck. They are not a substitute for the thing that raised NAMPT by 25–30% in an actual human trial, which was twelve weeks of exercise. The fair reading is that both belong in the picture, in that order.
References
- de Guia RM, Agerholm M, Nielsen TS, et al. Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle. Physiological Reports. 2019;7(12):e14139. PMCID: PMC6577427.
- Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science. 2009;324(5927):654-657. PMID: 19286518. DOI: 10.1126/science.1170803.
- Basse AL, Nielsen KN, Karavaeva I, et al. NAMPT-dependent NAD+ biosynthesis controls circadian metabolism in a tissue-specific manner. PNAS. 2023;120(14):e2220102120. PMID: 36996103. DOI: 10.1073/pnas.2220102120.
- Yaku K, Okabe K, Nakagawa T. NAD metabolism: implications in aging and longevity. Reviewed in: Yoshino M, et al. Nicotinamide phosphoribosyltransferase as a key molecule of the aging/senescence process. International Journal of Molecular Sciences. PMCID: PMC8037941.
- Poljsak B, Milisav I. The circadian NAD+ metabolism: impact on chromatin remodeling and aging. PMCID: PMC5165141.
- Brakedal B, Dölle C, Riemer F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metabolism. 2022;34(3):396-407.e6. PMID: 35235774. DOI: 10.1016/j.cmet.2022.02.001. ClinicalTrials.gov: NCT03816020.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.